Inventor · disambiguated record
Wagner Zago
Also filed as: ZAGO WAGNER · ZAGO WAGNER MARCELO
18 granted patents·20 pending applications·56 citations·filing 2008–2025
92Inventor score
Files withOTHAIR PROTHENA LTD15PROTHENA BIOSCIENCES LTD13PROTHENA BIOSCIENCE LTD2BARBOUR ROBIN1BARBOUR ROBINOO1
Top patents by PatentIndex Score
38 records- 0196US11440953B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2022·Granted Sep 13, 2022·3 cites·19 claims
- 0296US11434283B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·3 cites·19 claims
- 0395US11965005B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 23, 2024·1 cites·25 claims
- 0495US11434285B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 0595US11434284B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 0691US8003097B2Treatment of cerebral amyloid angiopathyJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2008·Granted Aug 23, 2011·41 cites·13 claims
- 0790US12247056B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2024·Granted Mar 11, 2025·0 cites·26 claims
- 0890US2025179161A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2024·Application pending·0 cites
- 0987US11952406B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 9, 2024·0 cites·25 claims
- 1087US11945849B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 2, 2024·0 cites·25 claims
- 1185US11692024B2Methods of treating AL amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Jul 4, 2023·2 cites·42 claims
- 1282US2023331828A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2022·Application pending·0 cites
- 1381US12049498B2Humanized antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·10 claims
- 1480US12049497B2Antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·9 claims
- 1580US2025282838A1Multi-Epitope Vaccine for the Treatment of Alzheimer's DiseaseOTHAIR PROTHENA LTD·Filed 2025·Application pending·0 cites
- 1677US12435129B2Anti-Aβ antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Oct 7, 2025·0 cites·14 claims
- 1776US12240894B2Methods of treating AL amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Mar 4, 2025·0 cites·25 claims
- 1876US2023183304A1Multi-Epitope Vaccine for the Treatment of Alzheimer's DiseaseBARBOUR ROBINOO·Filed 2021·Application pending·0 cites
- 1974US2025075007A1Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune CellsPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 2071US9272030B2Use of tau to monitor immunotherapyBLACK RONALD·Filed 2011·Granted Mar 1, 2016·1 cites·16 claims
- 2168US2025188158A1Treatment of Parkinson's DiseasePROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 2267US2025188159A1Methods of treating al amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 2365US12084491B2Treatment of Parkinson's diseasePROTHENA BIOSCIENCES LTD·Filed 2021·Granted Sep 10, 2024·0 cites·13 claims
- 2464US2023235048A1Antibodies recognizing sortilinIOANNOU ANDRIANI·Filed 2021·Application pending·0 cites
- 2562US2022213223A1Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune CellsPROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 2661US12372537B2Determination of Parkinson's diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Jul 29, 2025·0 cites·30 claims
- 2761US10562973B2Blood-brain barrier shuttles containing antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCE LTD·Filed 2015·Granted Feb 18, 2020·1 cites·40 claims
- 2860US2023348588A1Antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 2958US2025345418A1Methods of treating al amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 3057US2023355756A1Alpha-synuclein vaccine for the treatment of synucleinopathiesPROTHENA BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3157US2023355729A1Multiepitope vaccine for the treatment of alzheimer's diseaseBARBOUR ROBIN·Filed 2021·Application pending·0 cites
- 3257US2025186567A1Multiepitope vaccine for the treatment of alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2021·Application pending·0 cites
- 3356US2023364210A1ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASEOTHAIR PROTHENA LTD·Filed 2021·Application pending·0 cites
- 3456US2023302127A1Tau vaccine for the treatment of alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2021·Application pending·0 cites
- 3555US2023391859A1Anti-transthyretin antibodies and methods of use thereofNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 3653US2025084153A1Methods of treating al amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 3752US2020299397A1Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-SynucleinPROTHENA BIOSCIENCE LTD·Filed 2020·Application pending·0 cites
- 3843US2012282248A1Prevention and treatment of cerebral amyloid angiopathySCHROETER SALLY·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wagner Zago files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →